Dose | Group A Varicella vaccine without HSA | Group B Licensed varicella vaccine | Ratio (Group A/Group B) Post-dose 1 | ||||
---|---|---|---|---|---|---|---|
N | SC % (95Â % CI) | GMT (95Â % CI) | N | SC (95Â % CI) | GMT (95Â % CI) | GMT (95Â % CI) | |
IFA | |||||||
6Â weeks Post-dose 1 | 116 | 98.3 (93.9; 99.8) | 172.6 (141.6; 210.3) | 115 | 99.1 (95.3; 100) | 154.3(128.7; 185.0) | 1.12 (0.86; 1.46) |
6Â weeks Post-dose 2 | 115 | 100 (96.8; 100) | 1452.5 (1240.7; 1700.5) | 112 | 100 (96.8; 100) | 1395.4 (1183.0; 1645.9) | |
Dose | N | SR (95Â % CI) | GMC (95Â % CI) | N | SR (95Â % CI) | GMC (95Â % CI) | GMC (95Â % CI) |
ELISA | |||||||
6Â weeks Post-dose 1 | 116 | 98.3 (93.9; 99.8) | 123.5(107.9; 141.4) | 115 | 98.3 (93.9; 99.8) | 110.7 (98.4; 124.6) | 1.12 (0.93; 1.33) |
6Â weeks Post-dose 2 | 116 | 100 (96.9; 100) | 1013.6 (880.9; 1166.4) | 114 | 100 (96.8;100) | 999.2 (877.3; 1138.1) |